Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2025-04-23 Environmental & Social …
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
2024年度可持续发展报告
Environmental & Social Information Classification · 95% confidence The document is titled '年度可持续发展报告 2024' which translates to 'Annual Sustainability Report 2024' for 重药控股股份有限公司. It covers extensive Environmental, Social, and Governance (ESG) information, including governance structure, environmental management, social responsibility, and sustainability goals. The report period is the full year 2024, aligning with the fiscal year. It references compliance with Shenzhen Stock Exchange guidelines for sustainability reporting and includes detailed ESG performance metrics and initiatives. The document is lengthy (15,000 characters) and contains substantive content rather than just an announcement or summary. This matches the description of an Environmental & Social Information report (ESG report). Therefore, the appropriate classification is Environmental & Social Information (SR).
2025-04-23 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2024 Annual General Meeting (AGM) of shareholders for the company 重药控股股份有限公司. It details the meeting date, voting procedures, proposals to be voted on (including annual reports and financial statements), and other logistical information related to the AGM. It does not contain the actual annual report or financial statements but rather the announcement and instructions for the AGM. The document length is about 4859 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-23 Chinese
2024年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2024年度董事会工作报告' which translates to '2024 Annual Board Work Report'. It details the board of directors' activities throughout the year 2024, including meetings held, resolutions passed, financial performance summary, committee activities, independent directors' work, information disclosure, and investor relations management. The content focuses on the board's work and governance rather than presenting full financial statements or audit results. It is a comprehensive report on board activities and governance for the year, which fits the category of Board/Management Information (MANG). The document length is substantial (over 10,000 characters), indicating it is a full report rather than a brief announcement. There is no indication that this is an annual report (10-K) or audit report (AR), nor is it a proxy statement or other category. Therefore, the best classification is MANG with high confidence.
2025-04-23 Chinese
关于计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the provision for asset impairment for the fiscal year ending December 31, 2024. It details the amounts of impairment provisions for various asset categories such as receivables, inventory, and goodwill. The document includes references to accounting standards and the impact of the impairment on the company's net profit and equity. It is a formal disclosure of an accounting estimate adjustment rather than a full financial report or audit report. The document length is 2174 characters, which is relatively short and focused on a specific accounting matter. It does not contain comprehensive financial statements or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like Annual Report, Audit Report, or Interim Report.
2025-04-23 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 13th meeting of the 9th Board of Directors of the company. It includes voting results on various reports and proposals such as the 2024 annual general manager work report, 2024 board work report, internal control evaluation report, annual financial statements, profit distribution plan, and other governance and operational matters. It also references that many of these reports are disclosed separately on the same day. The document is not the reports themselves but a formal announcement of the board meeting decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is 2513 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the classification is MANG with high confidence.
2025-04-23 Chinese
2024年度独立董事述职报告（蔡仲曦）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2024 by an independent director of the company. It details the director's background, attendance at board and shareholder meetings, participation in committees, communication with auditors, focus on related party transactions, financial reporting, audit firm appointment, nomination of directors, and remuneration matters. The content is a detailed report on the independent director's duties and activities over the year, which is a form of board/management information rather than a full annual report or audit report. It is not a financial statement or earnings release, nor is it a regulatory filing or announcement. The document length is 2819 characters, which is relatively short but contains substantive content about board activities and governance. Therefore, the best fitting category is Board/Management Information (MANG).
2025-04-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.